A$0.215 -0.0 -2.3%
Last Trade - 5:11am
| Market Cap | £23.8m |
| Enterprise Value | £16.4m |
| Revenue | £10.1m |
| Position in Universe | 1142nd / 1831 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.000 | 0.002 | 37.6 | 27.7 | 14.4 | 17.9 | +11,678% | ||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Elixinol Global Limited is an Australia-based company. The Company owns and operates hemp and medicinal cannabis industries. The Company is focused on developing, manufacturing and distributing industrial hemp products and early stage medical cannabis business.
| Last Annual | December 31st, 2019 |
| Last Interim | June 30th, 2020 |
| Incorporated | September 4, 2017 |
| Public Since | January 8, 2018 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Consumer Cyclicals |
| Industry | Specialty Retailers |
| Index | |
| Exchange | Australian Stock Exchange - SEATS |
| Shares in Issue | 192,703,954 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Gateway TWR L 36 1 Macquarie Pl, Sydney, 2000, Australia |
| Web | http://elixinolglobal.com/ |
| Phone | +61 2 40444585 |
| Contact | () |
| Auditors | Deloitte Touche Tohmatsu |
As of 5:11am, shares in Elixinol Global are trading at A$0.215, giving the company a market capitalisation of £23.8m. This share price information is delayed by 15 minutes.
Shares in Elixinol Global are currently trading at A$0.215 and the price has moved by -46.34% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Elixinol Global price has moved by -47.07% over the past year.
Of the analysts with advisory recommendations for Elixinol Global, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Elixinol Global is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Elixinol Global is scheduled to issue upcoming financial results on the following dates:
Elixinol Global does not currently pay a dividend.
Elixinol Global does not currently pay a dividend.
Elixinol Global does not currently pay a dividend.
To buy shares in Elixinol Global you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Elixinol Global are currently trading at A$0.215, giving the company a market capitalisation of £23.8m.
Here are the trading details for Elixinol Global:
Based on an overall assessment of its quality, value and momentum, Elixinol Global is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Elixinol Global are currently priced at A$0.215. At that level they are trading at 0.45% premium to the analyst consensus target price of 0.00.
Analysts covering Elixinol Global currently have a consensus Earnings Per Share (EPS) forecast of -0.093 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Elixinol Global. Over the past six months, the relative strength of its shares against the market has been 22.12%. At the current price of A$0.215, shares in Elixinol Global are trading at 17.85% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Elixinol Global.
Elixinol Global's management team is headed by:
Here are the top five shareholders of Elixinol Global based on the size of their shareholding:
